Erasca (ERAS) Amortizatization of Intangibles (2020 - 2026)
Erasca posted quarterly Amortizatization of Intangibles of $746000.0 for Q1 2026, down 62.44% year-on-year from $2.0 million in Q1 2025, and up 28.62% on a QoQ basis from $580000.0 in Q4 2025.
Erasca (ERAS) has 7 years of Amortizatization of Intangibles data on file, last reported at $746000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles fell 62.44% year-over-year to $746000.0; the trailing twelve-month figure through Mar 2026 stood at $3.8 million (down 58.34% YoY), and the FY2025 full-year result was $5.1 million, down 46.96% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $746000.0, up from $580000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $2.5 million in Q3 2024 and bottomed at -$17000.0 in Q1 2022.
- The 5-year median for Amortizatization of Intangibles is $1.4 million (2023), against an average of $1.4 million.
- The widest annual swing landed in 2023, when Amortizatization of Intangibles surged 11658.33%; it then plunged 75.35% in 2025.
- A 5-year view of Amortizatization of Intangibles shows it stood at $825000.0 in 2022, then soared by 166.06% to $2.2 million in 2023, then climbed by 7.2% to $2.4 million in 2024, then slumped by 75.35% to $580000.0 in 2025, then advanced by 28.62% to $746000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $746000.0 (Q1 2026), $580000.0 (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Erasca | 4.21 Bn | 3.97 Bn | - | 746,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 746,000.00 |
| Mar 31, 2026 | 746,000.00 |
| Dec 31, 2025 | 580,000.00 |
| Dec 31, 2025 | 580,000.00 |
| Sep 30, 2025 | 1.02 Mn |
| Sep 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Mar 31, 2025 | 1.99 Mn |
| Mar 31, 2025 | 1.99 Mn |
| Dec 31, 2024 | 2.35 Mn |
| Dec 31, 2024 | 2.35 Mn |
| Sep 30, 2024 | 2.52 Mn |
| Sep 30, 2024 | 2.52 Mn |
| Jun 30, 2024 | 2.38 Mn |
| Jun 30, 2024 | 2.38 Mn |
| Mar 31, 2024 | 2.34 Mn |
| Mar 31, 2024 | 2.34 Mn |
| Dec 31, 2023 | 2.20 Mn |
| Dec 31, 2023 | 2.20 Mn |
| Sep 30, 2023 | 2.37 Mn |
| Sep 30, 2023 | 2.37 Mn |
| Jun 30, 2023 | 1.41 Mn |
| Jun 30, 2023 | 1.41 Mn |
| Mar 31, 2023 | 975,000.00 |
| Mar 31, 2023 | 975,000.00 |
| Dec 31, 2022 | 825,000.00 |
| Dec 31, 2022 | 825,000.00 |
| Sep 30, 2022 | 174,000.00 |
| Sep 30, 2022 | 174,000.00 |
| Jun 30, 2022 | 12,000.00 |
| Jun 30, 2022 | 12,000.00 |
| Mar 31, 2022 | -17,000.00 |
| Mar 31, 2022 | -17,000.00 |
| Dec 31, 2021 | -33,000.00 |
| Dec 31, 2021 | -33,000.00 |
| Sep 30, 2021 | -29,000.00 |
| Sep 30, 2021 | -29,000.00 |
| Jun 30, 2021 | -33,000.00 |
| Jun 30, 2021 | -33,000.00 |
| Mar 31, 2021 | -13,000.00 |
| Mar 31, 2021 | -13,000.00 |
| Dec 31, 2020 | 2,000.00 |
| Dec 31, 2020 | 2,000.00 |
| Sep 30, 2020 | 16,000.00 |
| Sep 30, 2020 | 16,000.00 |